Tightening of pricing and market access, an increase in competitive intensity, unexpected safety signals, or manufacturing supply constraints within the GLP-1/GIP space could have a significant impact on their overall R&D returns
Theoretically, the L* value can change from 100 (absolute white) to 0 (absolute black)
Our procurement team also helps institutional buyers compare originator or generic supply routes without making therapeutic substitutions unless permitted by the buyers regulatory framework
2- Take notes of the dose, route of administration, and the manufacturer name (if specified by the provider)
Seyedi, F., Farsinejad, A., Nematollahi-Mahani, S